skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,512  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Middle Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells
Material Type:
Article
Add to My Research

Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1543-1550 [Peer Reviewed Journal]

Published by the American Society of Clinical Oncology. ;Published by the American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.9093 ;PMID: 25823737

Full text available

2
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Material Type:
Article
Add to My Research

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

The New England journal of medicine, 2018-11, Vol.379 (20), p.1895-1904 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806395 ;PMID: 30380365

Full text available

3
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Material Type:
Article
Add to My Research

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429

Full text available

4
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Material Type:
Article
Add to My Research

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

The New England journal of medicine, 2018-11, Vol.379 (20), p.1905-1914 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804923 ;PMID: 30379613

Full text available

5
SUCCOR cone study: conization before radical hysterectomy
Material Type:
Article
Add to My Research

SUCCOR cone study: conization before radical hysterectomy

International journal of gynecological cancer, 2022-02, Vol.32 (2), p.117-124 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002544 ;PMID: 35039455

Full text available

6
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study
Material Type:
Article
Add to My Research

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study

Journal of clinical oncology, 2020-04, Vol.38 (10), p.1030-1040 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03012 ;PMID: 32031867

Full text available

7
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Material Type:
Article
Add to My Research

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00739 ;PMID: 31487218

Full text available

8
N 6 -methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Material Type:
Article
Add to My Research

N 6 -methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification

Cell death & disease, 2020-10, Vol.11 (10), p.911 [Peer Reviewed Journal]

EISSN: 2041-4889 ;DOI: 10.1038/s41419-020-03071-y ;PMID: 33099572

Full text available

9
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Material Type:
Article
Add to My Research

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4095-4106 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01920 ;PMID: 33052760

Full text available

10
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Material Type:
Article
Add to My Research

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2129-2135 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.4391 ;PMID: 25732161

Full text available

11
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Material Type:
Article
Add to My Research

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

The lancet oncology, 2021-05, Vol.22 (5), p.609-619 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00056-5 ;PMID: 33845034

Full text available

12
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial
Material Type:
Article
Add to My Research

Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial

Journal of clinical oncology, 2021-11, Vol.39 (33), p.3682-3692 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.02530 ;PMID: 34506246

Full text available

13
Trends in cervical cancer incidence in sub-Saharan Africa
Material Type:
Article
Add to My Research

Trends in cervical cancer incidence in sub-Saharan Africa

British journal of cancer, 2020-07, Vol.123 (1), p.148-154 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0831-9 ;PMID: 32336751

Full text available

14
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study
Material Type:
Article
Add to My Research

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study

Journal of clinical oncology, 2022-03, Vol.40 (7), p.762-771 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02067 ;PMID: 34932394

Full text available

15
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21
Material Type:
Article
Add to My Research

Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21

Cancer biology & therapy, 2016-01, Vol.17 (1), p.104-113 [Peer Reviewed Journal]

2016 © Taylor & Francis Group, LLC 2016 ;2016 © Taylor & Francis Group, LLC 2016 Taylor & Francis Group, LLC ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2015.1108496 ;PMID: 26574780

Full text available

16
Cytology versus HPV testing for cervical cancer screening in the general population
Material Type:
Article
Add to My Research

Cytology versus HPV testing for cervical cancer screening in the general population

Cochrane database of systematic reviews, 2017-08, Vol.2018 (7), p.CD008587 [Peer Reviewed Journal]

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD008587.pub2 ;PMID: 28796882

Full text available

17
Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis

The lancet oncology, 2017-12, Vol.18 (12), p.1665-1679 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 1, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30700-3 ;PMID: 29126708

Full text available

18
Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL Study
Material Type:
Article
Add to My Research

Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL Study

Journal of clinical oncology, 2011-05, Vol.29 (13), p.1686-1691 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.32.0432 ;PMID: 21444878

Full text available

19
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening
Material Type:
Article
Add to My Research

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening

JNCI : Journal of the National Cancer Institute, 2018-05, Vol.110 (5), p.501-508 [Peer Reviewed Journal]

Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djx225 ;PMID: 29145648

Full text available

20
Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
Material Type:
Article
Add to My Research

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome

Neoplasia (New York, N.Y.), 2019-06, Vol.21 (6), p.591-601 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 1476-5586 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2019.04.003 ;PMID: 31055200

Full text available

Results 1 - 20 of 5,512  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,114)

Refine My Results

Creation Date 

From To
  1. Before 1976  (59)
  2. 1976 To 1987  (276)
  3. 1988 To 1999  (1,001)
  4. 2000 To 2012  (1,930)
  5. After 2012  (2,249)
  6. More options open sub menu

Language 

  1. English  (5,328)
  2. Japanese  (675)
  3. French  (72)
  4. Portuguese  (68)
  5. German  (39)
  6. Italian  (33)
  7. Spanish  (32)
  8. Polish  (23)
  9. Russian  (9)
  10. Swedish  (5)
  11. Chinese  (5)
  12. Norwegian  (4)
  13. Czech  (3)
  14. Hungarian  (1)
  15. Serbian  (1)
  16. Korean  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait